Therapeutic Effects of Rho Kinase Inhibitor on Experimental Diabetic Neuropathy

被引：0
|
作者：
Kanazawa, Yasushi
Utsunomiya, Kazunori
Ishizawa, Shou
Matoba, Keiichiro
Gojo, Atsushi
Yokota, Tamotsu
Kurata, Hideaki
Tajima, Naoko
Fujigasaki, Junko
机构：
来源：
DIABETES | 2009年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A228 / A228
页数：1
相关论文
共 50 条
  • [41] The New Therapeutic Concept of Using a Rho Kinase Inhibitor for the Treatment of Corneal Endothelial Dysfunction
    Okumura, Naoki
    Koizumi, Noriko
    Ueno, Morio
    Sakamoto, Yuji
    Takahashi, Hiroaki
    Hamuro, Junji
    Kinoshita, Shigeru
    CORNEA, 2011, 30 : S54 - S59
  • [42] Rho kinase inhibitor Y-27632 facilitates recovery from experimental peripheral neuropathy induced by anti-cancer drug cisplatin
    James, Sarah E.
    Dunham, Mayisha
    Carrion-Jones, Monica
    Murashov, Alexander
    Lu, Qun
    NEUROTOXICOLOGY, 2010, 31 (02) : 188 - 194
  • [43] Rho-kinase inhibitor restores glomerular fatty acid metabolism in diabetic kidney disease
    Nagai, Yosuke
    Matoba, Keiichiro
    Yako, Hideji
    Ohashi, Shinji
    Sekiguchi, Kensuke
    Mitsuyoshi, Etsuko
    Sango, Kazunori
    Kawanami, Daiji
    Utsunomiya, Kazunori
    Nishimura, Rimei
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 649 : 32 - 38
  • [44] Methylcobalamin effects on diabetic neuropathy and nerve protein kinase C in rats
    Mizukami, Hiroki
    Ogasawara, Saori
    Yamagishi, Shin-Ichiro
    Takahashi, Kazunori
    Yagihashi, Soroku
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2011, 41 (04) : 442 - 450
  • [45] Effect of the rho-kinase inhibitor hydroxyfasudil on bladder overactivity: An experimental rat model
    Masago, Toshihiko
    Watanabe, Takeshi
    Saito, Motoaki
    Kinoshita, Yukako
    Sato, Keisuke
    Miyagawa, Ikuo
    INTERNATIONAL JOURNAL OF UROLOGY, 2009, 16 (10) : 842 - 847
  • [46] Therapeutic significance of Y-27632, a Rho-kinase inhibitor, on the established liver fibrosis
    Murata, T
    Arii, S
    Mori, A
    Imamura, M
    JOURNAL OF SURGICAL RESEARCH, 2003, 114 (01) : 64 - 71
  • [47] Effects of fasudil, a Rho-kinase inhibitor, on myocardial preconditioning in anesthetized rats
    Demiryürek, S
    Kara, AF
    Çelik, A
    Babül, A
    Tarakçioglu, M
    Demiryürek, AT
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 527 (1-3) : 129 - 140
  • [48] CARDIOVASCULAR EFFECTS OF THE NOVEL RHO-KINASE INHIBITOR SAR407899
    Loehn, M.
    Plettenburg, O.
    Ivashchenko, Y.
    Kannt, A.
    Schaefer, M.
    Linz, W.
    Kohlmann, M.
    Herbert, J. M.
    Janiak, P.
    O'Connor, S. E.
    Ruetten, H.
    JOURNAL OF HYPERTENSION, 2009, 27 : S313 - S313
  • [49] Alleviating Effects of AS1892802, a Rho Kinase Inhibitor, on Osteoarthritic Disorders in Rodents
    Takeshita, Nobuaki
    Yoshimi, Eiji
    Hatori, Chie
    Kumakura, Fumiyo
    Seki, Nobuo
    Shimizu, Yasuaki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 (04) : 481 - 489
  • [50] Protective effects of Rho kinase inhibitor fasudil on rats with chronic kidney disease
    Kushiyama, Taketoshi
    Oda, Takashi
    Yamamoto, Kojiro
    Higashi, Keishi
    Watanabe, Atsushi
    Takechi, Hanako
    Uchida, Takahiro
    Oshima, Naoki
    Sakurai, Yutaka
    Miura, Soichiro
    Kumagai, Hiroo
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2013, 304 (11) : F1325 - F1334
12345